Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take Newsletter

Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes

Read Now

News and Insights

Showing items 1 to3 of 6

Categories
Tags
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Results 1

Date
Our Take: Pfizer wins bidding war to acquire Metsera
Insight
Our Take Newsletter
November 10, 2025

Our Take: Pfizer wins bidding war to acquire Metsera

Learn More
November 10, 2025
Pfizer
2025
ourtake
Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs
Insight
Our Take Newsletter
November 3, 2025

Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs

Learn More
November 3, 2025
PBM
2025
ourtake
prescription
CVS
Our Take: An uptick in health system collaborations and affiliations
Insight
Our Take Newsletter
October 27, 2025

Our Take: An uptick in health system collaborations and affiliations

Learn More
October 27, 2025
2025
health system
collaboration
Our Take: Amazon to offer pharmacy kiosks at One Medical clinics
Insight
Our Take Newsletter
October 13, 2025

Our Take: Amazon to offer pharmacy kiosks at One Medical clinics

Learn More
October 13, 2025
amazon
rx
2025
Our Take: New California laws take aim at PBMs and more
Insight
Our Take Newsletter
October 20, 2025

Our Take: New California laws take aim at PBMs and more

Learn More
October 20, 2025
PBM
virtual primary care
ourtake
2025
Our Take: Feature: Notable recent transactions among Big Pharma and life sciences companies
Insight
Our Take Newsletter
September 22, 2025

Our Take: Feature: Notable recent transactions among Big Pharma and life sciences companies

Learn More
September 22, 2025
big pharma
ourtake
Gilead Sciences
Darwin's Our Take: Genmab agrees to acquire Dutch biotech Merus for $8 billion
Insight
Our Take Newsletter
October 6, 2025

Darwin's Our Take: Genmab agrees to acquire Dutch biotech Merus for $8 billion

Learn More
October 6, 2025
acquisition
Our Take: Feature - GAO report on physician consolidation
Insight
Our Take Newsletter
September 29, 2025

Our Take: Feature - GAO report on physician consolidation

Learn More
September 29, 2025
acquisition
business
health systems
Our Take: Feature: CBO report analyzes 565% increase in 340B drug spending over 11 years
Insight
Our Take Newsletter
September 15, 2025

Our Take: Feature: CBO report analyzes 565% increase in 340B drug spending over 11 years

Learn More
September 15, 2025
drug
health systems
Our Take: Evernorth invests $3.5 billion in Shields Health, HonorHealth acquires Evernorth Care clinics
Insight
Our Take Newsletter
September 8, 2025

Our Take: Evernorth invests $3.5 billion in Shields Health, HonorHealth acquires Evernorth Care clinics

Learn More
September 8, 2025
healthcare
merger
acquisition
Our Take: Epic shines a spotlight on generative AI projects at annual Users Group Meeting
Insight
Our Take Newsletter
August 25, 2025

Our Take: Epic shines a spotlight on generative AI projects at annual Users Group Meeting

Learn More
August 25, 2025
artificial intelligence
epic
healthcare podcast
Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada
Insight
Our Take Newsletter
December 5, 2020

Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada

Learn More
December 5, 2020
canada
drug
drugs
fda
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.